Last updated: August 27, 2024
Sponsor: Ente Ospedaliero Cantonale, Bellinzona
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cartilage Injuries
Treatment
Nanofracture
Clinical Study ID
NCT05660161
ORL-ORT-037
Ages 16-50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with cartilage lesions of the knee scheduled for surgery
Age 16-50
BMI between 18.5 and 30 points
Ability to give informed consent
Exclusion
Exclusion Criteria:
Uncorrected knee instability
Meniscectomy > 50%
Uncorrected knee misalignment
Uncontrolled metabolic diseases
Inability to give informed consent
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Nanofracture
Phase:
Study Start date:
March 02, 2023
Estimated Completion Date:
January 31, 2026
Connect with a study center
EOC
Lugano, 6900
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.